Polybrominated diphenyl ether exposure suppresses cytokines important in the defence to coxsackievirus B3 infection in mice

Toxicology Letters

Volumn 184, Issue 2, 2009, Pages 107-113

  Lundgren, Magnus ^a,b   Darnerud, Per Ola ^a   Blomberg, Jonas ^b   Friman, Göran ^b   Ilbäck, Nils Gunnar ^a,b  

^a NATIONAL FOOD ADMINISTRATION   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chemokines; Coxsackievirus; Cytokines; Infection; PBDE

Indexed keywords

BROMKAL; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; POLYBROMINATED DIPHENYL ETHER; POLYBROMINATED DIPHENYL ETHER 99; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; COXSACKIE VIRUS B3; DEATH; FEMALE; HOST RESISTANCE; LIVER; MOUSE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; COXSACKIEVIRUS INFECTIONS; CYTOKINES; ENTEROVIRUS B, HUMAN; ENVIRONMENTAL POLLUTANTS; FEMALE; HALOGENATED DIPHENYL ETHERS; IMMUNITY, INNATE; LIVER; MICE; MICE, INBRED BALB C; PANCREAS;

COXSACKIEVIRUS; MUS;

EID: 58149461845     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2008.10.021     Document Type: Article

References (44)

1. Beineke A., Siebert U., McLachlan M., Bruhn R., Thron K., Failing K., Muller G., and Baumgartner W. Investigations of the potential influence of environmental contaminants on the thymus and spleen of harbor porpoises (Phocoena phocoena). Environ. Sci. Technol. 39 (2005) 3933-3938
2. Beineke A., Siebert U., Muller G., and Baumgartner W. Increased blood interleukin-10 mRNA levels in diseased free-ranging harbor porpoises (Phocoena phocoena). Vet. Immunol. Immunopathol. 115 (2007) 100-106
3. Beisel W.R. Metabolic response of the host to infections. In: Feigin R.D., and Cherry J.D. (Eds). Textbook of Pediatric Infectious Disease (1998), WB Saunders, Philadelphia 54-69
4. Burleson G.R., Lebrec H., Yang Y.G., Ibanes J.D., Pennington K.N., and Birnbaum L.S. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on influenza virus host resistance in mice. Fundam. Appl. Toxicol. 29 (1996) 40-47
5. Conti P., and DiGioacchino M. MCP-1 and RANTES are mediators of acute and chronic inflammation. Allergy Asthma Proc. 22 (2001) 133-137
6. Cooper A.M., Magram J., Ferrante J., and Orme I.M. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 186 (1997) 39-45
7. Darnerud P.O. Toxic effects of brominated flame retardants in man and in wildlife. Environ. Int. 29 (2003) 841-853
8. Darnerud P.O., Eriksen G.S., Johannesson T., Larsen P.B., and Viluksela M. Polybrominated diphenyl ethers: occurrence, dietary exposure, and toxicology. Environ Health Perspect. 109 Suppl. 1 (2001) 49-68
9. Darnerud P.O., and Risberg S. Tissue localisation of tetra- and pentabromodiphenyl ether congeners (BDE-47, -85 and -99) in perinatal and adult C57BL mice. Chemosphere 62 (2006) 485-493
10. Darnerud P.O., Wong J., Bergman A., and Ilback N.G. Common viral infection affects pentabrominated diphenyl ether (PBDE) distribution and metabolic and hormonal activities in mice. Toxicology 210 (2005) 159-167
11. De Swart R.L., Ross P.S., Timmerman H.H., Vos H.W., Reijnders P.J., Vos J.G., and Osterhaus A.D. Impaired cellular immune response in harbour seals (Phoca vitulina) feeding on environmentally contaminated herring. Clin. Exp. Immunol. 101 (1995) 480-486
12. De Swart R.L., Ross P.S., Vos J.G., and Osterhaus A.D. Impaired immunity in harbour seals (Phoca vitulina) exposed to bioaccumulated environmental contaminants: review of a long-term feeding study. Environ. Health Perspect. 104 Suppl 4 (1996) 823-828
13. Fairweather D., Kaya Z., Shellam G.R., Lawson C.M., and Rose N.R. From infection to autoimmunity. J. Autoimmun. 16 (2001) 175-186
14. Fairweather D., and Rose N.R. Women and autoimmune diseases. Emerg. Infect. Dis. 10 (2004) 2005-2011
15. Fairweather D., and Rose N.R. Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. Methods 41 (2007) 118-122
16. Frisancho-Kiss S., Nyland J.F., Davis S.E., Frisancho J.A., Barrett M.A., Rose N.R., and Fairweather D. Sex differences in coxsackievirus B3-induced myocarditis: IL-12Rbeta1 signaling and IFN-gamma increase inflammation in males independent from STAT4. Brain Res. 1126 (2006) 139-147
17. Funseth E., Pahlman M., Eloranta M.L., Friman G., and Ilback N.G. Effects of coxsackievirus B3 infection on the acute-phase protein metallothionein and on cytochrome P-4501A1 involved in the detoxification processes of TCDD in the mouse. Sci. Total Environ. 284 (2002) 37-47
18. Funseth E., Wesslen L., Lindh U., Friman G., and Ilback N.G. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on trace elements, inflammation and viral clearance in the myocardium during coxsackievirus B3 infection in mice. Sci. Total Environ. 284 (2002) 135-147
19. Ilback N.G., Benyamin G., Lindh U., Fohlman J., and Friman G. Trace element changes in the pancreas during viral infection in mice. Pancreas 26 (2003) 190-196
20. Ilback N.G., Fohlman J., Slorach S., and Friman G. Effects of the immunomodulator LS 2616 on lymphocyte subpopulations in murine Coxsackievirus B3 myocarditis. J. Immunol. 142 (1989) 3225-3228
21. Ilback N.G., and Friman G. Interactions among infections, nutrients and xenobiotics. Crit. Rev. Food Sci. Nutr. 47 (2007) 499-519
22. Ilback N.G., Wesslén L., Fohlman J., and Friman G. Effects of methyl mercury on cytokines, inflammation and virus clearance in a common infection (coxsackie B3 myocarditis). Toxicol. Lett. 89 (1996) 19-28
23. Kadowaki N., Antonenko S., Lau J.Y., and Liu Y.J. Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J. Exp. Med. 192 (2000) 219-226
24. Khetsuriani N., Lamonte A., Oberste M.S., and Pallansch M. Neonatal enterovirus infections reported to the national enterovirus surveillance system in the United States, 1983-2003. Pediatr. Infect. Dis. J. 25 (2006) 889-893
25. Lilienthal H., Hack A., Roth-Harer A., Grande S.W., and Talsness C.E. Effects of developmental exposure to 2,2,4,4,5-pentabromodiphenyl ether (PBDE-99) on sex steroids, sexual development, and sexually dimorphic behavior in rats. Environ. Health Perspect. 114 (2006) 194-201
26. Lohmann T., Laue S., Nietzschmann U., Kapellen T.M., Lehmann I., Schroeder S., Paschke R., and Kiess W. Reduced expression of Th1-associated chemokine receptors on peripheral blood lymphocytes at diagnosis of type 1 diabetes. Diabetes 51 (2002) 2474-2480
27. Lundgren M., Darnerud P.O., Molin Y., Lilienthal H., Blomberg J., and Ilback N.G. Coxsackievirus B3 infection and PBDE exposure causes organ-specific effects on CYP-gene expression in the mouse. Toxicology 242 (2007) 91-99
28. Lundgren M., Darnerud P.O., Molin Y., Lilienthal H., Blomberg J., and Ilback N.G. Viral infection and PBDE exposure interact on CYP gene expression and enzyme activities in the mouse liver. Toxicology 242 (2007) 100-108
29. Mohamed N., Elfaitouri A., Fohlman J., Friman G., and Blomberg J. A sensitive and quantitative single-tube real-time reverse transcriptase-PCR for detection of enteroviral RNA. J. Clin. Virol. 30 (2004) 150-156
30. Morgan E.T. Regulation of cytochromes P450 during inflammation and infection. Drug Metab. Rev. 29 (1997) 1129-1188
31. Muller U., Steinhoff U., Reis L.F., Hemmi S., Pavlovic J., Zinkernagel R.M., and Aguet M. Functional role of type I and type II interferons in antiviral defense. Science 264 (1994) 1918-1921
32. Oxenius A., Karrer U., Zinkernagel R.M., and Hengartner H. IL-12 is not required for induction of type 1 cytokine responses in viral infections. J. Immunol. 162 (1999) 965-973
33. Potvin D.M., Metzger D.W., Lee W.T., Collins D.N., and Ramsingh A.I. Exogenous interleukin-12 protects against lethal infection with coxsackievirus B4. J. Virol. 77 (2003) 8272-8279
34. Roivainen M. Enteroviruses: new findings on the role of enteroviruses in type 1 diabetes. Int. J. Biochem. Cell Biol. 38 (2006) 721-725
35. Salazar-Mather T.P., and Hokeness K.L. Calling in the troops: regulation of inflammatory cell trafficking through innate cytokine/chemokine networks. Viral Immunol. 16 (2003) 291-306
36. Salazar-Mather T.P., and Hokeness K.L. Cytokine and chemokine networks: pathways to antiviral defense. Curr. Top. Microbiol. Immunol. 303 (2006) 29-46
37. Siddiqi M.A., Laessig R.H., and Reed K.D. Polybrominated diphenyl ethers (PBDEs): new pollutants-old diseases. Clin. Med. Res. 1 (2003) 281-290
38. Stechova K., Bohmova K., Vrabelova Z., Sepa A., Stadlerova G., Zacharovova K., and Faresjo M. High T-helper-1 cytokines but low T-helper-3 cytokines, inflammatory cytokines and chemokines in children with high risk of developing type 1 diabetes. Diabetes Metab. Res. Rev. 23 (2007) 462-471
39. Van den Berg M., Birnbaum L.S., Denison M., De Vito M., Farland W., Feeley M., et al. The 2005 World Health Organization reevaluation of human and Mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol. Sci. 93 2 (2006) 223-241
40. Vogel C.F., Nishimura N., Sciullo E., Wong P., Li W., and Matsumura F. Modulation of the chemokines KC and MCP-1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice. Arch Biochem. Biophys. 461 (2007) 169-175
41. Warren T.K., Mitchell K.A., and Lawrence B.P. Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) suppresses the humoral and cell-mediated immune responses to influenza A virus without affecting cytolytic activity in the lung. Toxicol. Sci. 56 (2000) 114-123
42. Wessely R. Coxsackieviral replication and pathogenicity: lessons from gene modified animal models. Med. Microbiol. Immunol. (Berl.) 193 (2004) 71-74
43. WHO, 1994. Polybrominated biphenyls. In: IPCS Environmental Health Criteria No. 152, Geneva.
44. Woodruff J.F. Viral myocarditis. A review. Am. J. Pathol. 101 (1980) 425-484